BioSpace News Archive

Deals

BioVie Announces Closing of Acquisition of BioPharma Assets from Privately Held NeurMedixCompany Expects to Commence Enrollment in Pivotal Phase 3 Alzheimer’s Trial in Mid-2021

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or “Company”) today announced the closing of its previously announced acquisition of the biopharmaceutical assets of NeurMedix, Inc.

June 11, 2021
·
3 min read
Drug Development

ORYZON Presents Iadademstat ALICE 30-Month Data at EHA-2021, Confirming Positive and Robust Efficacy in Combination with Azacitidine in AML

Oryzon Genomics, S.A.presented today new positive efficacy data from its ongoing Phase IIa ALICE trial.

June 11, 2021
·
7 min read
Deals

atai Life Sciences Announces Launch of Initial Public Offering

atai Life Sciences B.V. today announced the commencement of a proposed underwritten initial public offering of 14,286,000 of its common shares.

June 11, 2021
·
2 min read
Lone Star Bio

United Imaging Splashes Out at SNMMI 2021 With Clinical and Preclinical Technologies, Total-body AI, and Award-Winning Business Programs

United Imaging, a global leader in advanced medical imaging and radiotherapy equipment celebrating its tenth anniversary, announced a number of featured products and is highlighting several distinguished speakers at this year’s SNMMI, where it is a Silver Sponsor.

June 11, 2021
·
4 min read
Business

Sorrento Announces Clinical Research Agreement With Mayo Clinic and FDA Clearance for the First Phase 1b Pilot Study Using Sofusa Lymphatic Drug Delivery Technology to Deliver Ipilimumab in Patients With Melanoma

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced a research collaboration agreement with Mayo Clinic to conduct human clinical proof of concept studies using the Sofusa Lymphatic Drug Delivery System (S-LDDS) technology across multiple products and indications

June 11, 2021
·
6 min read
BCG Vaccine Market Size to Reach USD 73.02 Million in 2028, Says Reports and Data

Increasing incidence of TB cases worldwide, technological advancements in vaccine discovery and developments, and implementation of favorable government policies are some key factors driving market growth.

June 11, 2021
·
5 min read
Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture

Hemostemix has obtained a new copy of its clinical trial data base from a former service provider who originally activated the clinical trial and who managed the data base for approximately the first two years of the clinical trial.

June 11, 2021
·
11 min read
Sona Discontinues Clinical Trial for COVID-19 Rapid Saliva Test

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021.

June 11, 2021
·
4 min read
Synthetic Biology Market Hits US$ 56,044.9 Mn by 2025 COVID-19 Impacts Global Analysis and Forecasts by The Insight Partners

The report highlights trends prevailing in the market, and the factors driving and hindering the market growth.

June 11, 2021
·
6 min read
Healthcare CMO Market Increasing Patent Cliffs to Drive Global Healthcare CMO Market Growth

The global healthcare CMO market is expected to reach US$ 223,355.6 Mn in 2027 from US$ 80,479.4 in 2018.

June 11, 2021
·
5 min read